What troubles are Catapult facing now? It has met its target revenue as per FY18 guidance (albeit at the low end), but that is considered 'meeting guidance'. The share price drop recently is driven by fear that the global markets will tank and everyone is selling due to fear. What fundamentals have changed for Catapult? The company managed to lift up XOS revenue growth from meagre 5% in FY17 to 9% in FY18, so that's a good thing. It managed to turn at least operating cashflow positive (bear in mind it's still a growing company). I very much prefer Catapult to keep investing its money to grow the business in scale. The company is targeting to triple or quadruple its Prosumer sales in FY19 (which will drive brand value and stickiness) as it reaches for the bigger pool of customers. Has it failed yet? Oh...why is it trading as if the company has failed?
I remember the despair of people on Hotcopper for Nearmap when it dropped from close to a $1 all the way back to $0.40 2 years ago. See where it is now? No one had any trust in the new Nearmap CEO at all. Hotcopper was full of people blaming him for the woes in share price. Has Nearmap now actually made any profit? Is it already group wise cash flow positive? No! Yet its market cap is ~$700M!
Key question is: What is different about Catapult compared to Nearmap in terms of the stage of its growth in the industry? The only difference is that Catapult's shares is much more easily manipulated because it is thinly traded with large majority of shares held by management or directors! Hence, it's subjected to wild swings in share price.
We just need someone to help stabilise the share price (some market maker who has $10M to spare)!
- Forums
- ASX - By Stock
- CAT
- Ann: Management Changes
Ann: Management Changes, page-10
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.42 |
Change
0.030(0.88%) |
Mkt cap ! $638.2M |
Open | High | Low | Value | Volume |
$3.41 | $3.51 | $3.34 | $5.142M | 1.509M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $3.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.47 | 6413 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.980 |
1 | 4986 | 0.970 |
1 | 1036 | 0.965 |
2 | 32659 | 0.960 |
2 | 41512 | 0.940 |
Price($) | Vol. | No. |
---|---|---|
0.990 | 1 | 1 |
1.000 | 42518 | 3 |
1.010 | 10000 | 1 |
1.020 | 25000 | 1 |
1.040 | 18507 | 4 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
CAT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online